ArticleJournal of endocrinological investigation2024

Comparison of SGLT2 inhibitors vs. DPP4 inhibitors for patients with metabolic dysfunction associated fatty liver disease and diabetes mellitus.

Y Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.